Position
State Street in Neumora Therapeutics, Inc.
Back to the book · All holders of NMRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$99.7K$1.95 → $1.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 388.9K | $696.2K | — | — | — | 0.0% |
| Q1 2026 | 398.7K | $777.5K | $1.95 | $62.2K | $19.1K | 0.0% |
| Q2 2026 | 1.58M | $2.69M | $1.70 | −$99.7K | $2.01M | 0.0% |